Physician profile
Jonathan Gabor
NPI 1497384598
$7,554.92
in general payments reported to CMS, 2019-2025
12 companies · $7,555 in 2025
The $7,555 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $7,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,095 · Food and Beverage: $3,459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,095.43 |
| Food and Beverage | $3,459.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vb Spine LLC | $2,782.92 | 2025 | Everest Spinal System |
| Arthrex, INC. | $1,309.14 | 2025 | |
| Medtronic, INC. | $590.29 | 2025 | Aquamantys(Tm), Catalyft Pl Expandable Interbody System, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Si-Bone, INC. | $537.81 | 2025 | |
| Globus Medical, INC. | $494.99 | 2025 | Xlif, Anthem, Reline |
| Suvon Surgical LLC | $463.43 | 2025 | |
| Depuy Synthes Sales INC. | $440.66 | 2025 | Teligen, Conduit, Velys |
| Cerapedics INC. | $262.01 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Choice Spine, LLC | $247.73 | 2025 | Veo Lateral Interbody Fusion System, Thunderbolt Minimally Invasive Pedicle Screw Systems, Triton |
| Acera Surgical, INC. | $169.80 | 2025 | Restrata Wound Matrix |
| Augmedics INC. | $138.87 | 2025 | Xvision |
| Avanos Medical | $117.27 | 2025 | Coolief Cooled Radiofrequency |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Gabor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.